Fasting Predictors of OGTT and MMTT Response
This trial is active, not recruiting.
|Conditions||prediabetes, hypertension, obesity, cardiovascular disease|
|Sponsor||Health Diagnostic Laboratory, Inc.|
|Start date||August 2013|
|End date||August 2018|
|Trial size||1000 participants|
|Trial identifier||NCT01998867, R2013-1003|
1. To develop a database containing matched information from dynamic tests of postprandial glycemic control (OGTT or MMTT), results of a broad panel of fasting biomarkers, and clinical information related to diabetes risk obtain through subject interview.
2. To use the database to identify fasting biomarkers and associated algorithms to best predict parameters derived from dynamic tests (OGTT or MMTT) such as Insulin Glucose Tolerance (IGT), impaired first phase insulin response, etc., controlling for clinical information such as current medication use.
Identify fasting biomarkers and associated algorithms to predict parameters
time frame: Baseline
Male or female participants at least 18 years old.
Inclusion Criteria: - Weight >95 Exclusion Criteria: - Prior diagnosis of Diabetes
|Official title||Identification of Fasting Biomarkers That Predict Responses to the Oral Glucose Tolerance Test (OGTT) and Mixed Meal Tolerance Test (MMTT)|
|Principal investigator||Szilard Voros, MD|
Call for more information